International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 5 September-October 2024 Submit your research before last 3 days of October to publish your research paper in the issue of September-October.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 6 Issue 5
September-October 2024

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Psychiatric Comorbidities in Patients with Alcohol Use Disorder

Author(s) Rose Haba, Arun Chandran Ramachandran
Country India
Abstract Alcohol Use Disorder (AUD) represents a major public health problem that has been increasing in India and all over the world. Alcohol users have a three-fold increased risk of developing another psychiatric disorder. Hence, the purpose of this study was to assess the magnitude of psychiatric comorbidities in patients with AUD and to describe the prescription pattern of drugs used in their management. The prevalence of Depression and Generalized Anxiety Disorder (GAD) among AUD patients was respectively found to be 37.01% and 32.20% considering from mild to severe level of disorder. A significant association was found between AUD patients diagnosed with Depression and those diagnosed with GAD with p-value significant at <0.05, where 30.79% of patients were having both Depression and GAD. From the treatment view, Selective Serotonin Reuptake Inhibitors (SSRIs) especially Escitalopram made up 94.44% of antidepressants used to treat depressive AUD patients. Lorazepam (47.5%) was the most prescribed benzodiazepine drug used to treat AUD patients with GAD. From this study, it is evident that psychiatric comorbidities are common in patients diagnosed with AUD. Therefore, a thorough assessment of the mental health of such patients is necessary. A proper treatment strategy should be planned and implemented to provide an effective treatment care to AUD patients alone and to those experiencing any other psychiatric comorbidities at the same time, thereby promoting better health outcomes and preventing alcohol relapse and withdrawal.
Keywords Alcohol Use Disorder, Depression, Generalized Anxiety Disorder
Field Medical / Pharmacy
Published In Volume 6, Issue 5, September-October 2024
Published On 2024-09-05
Cite This Psychiatric Comorbidities in Patients with Alcohol Use Disorder - Rose Haba, Arun Chandran Ramachandran - IJFMR Volume 6, Issue 5, September-October 2024. DOI 10.36948/ijfmr.2024.v06i05.27139
DOI https://doi.org/10.36948/ijfmr.2024.v06i05.27139
Short DOI https://doi.org/gwfgrk
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 5Cover Page Vol 6 Isu 4Cover Page Vol 6 Isu 3

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9898-5948-55 editor@ijfmr.com